34358 Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis (AD): Results from an open-label extension (OLE) trial up to 4 years

Autor:	Jacob P. Thyssen, Andrew Blauvelt, Benjamin Lockshin, Ryszard Galus, Charles Lynde, Jing Xiao, Noah A. Levit, Ainara Rodríguez Marco, Arsalan Shabbir
Rok vydání:	2022
Předmět:	Dermatology
Zdroj:	Journal of the American Academy of Dermatology. 87:AB180
ISSN:	0190-9622
DOI:	10.1016/j.jaad.2022.06.750
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b980b0c84f11fd7fb1f2b39bf165b165 https://doi.org/10.1016/j.jaad.2022.06.750 Zobrazit plný text záznamu Full Text from ScienceDirect